AU2004319797A1 - Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs with an extended therapeutic window - Google Patents

Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs with an extended therapeutic window Download PDF

Info

Publication number
AU2004319797A1
AU2004319797A1 AU2004319797A AU2004319797A AU2004319797A1 AU 2004319797 A1 AU2004319797 A1 AU 2004319797A1 AU 2004319797 A AU2004319797 A AU 2004319797A AU 2004319797 A AU2004319797 A AU 2004319797A AU 2004319797 A1 AU2004319797 A1 AU 2004319797A1
Authority
AU
Australia
Prior art keywords
erythropoietin
injury
therapeutic
administered
tissue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2004319797A
Other languages
English (en)
Other versions
AU2004319797A8 (en
Inventor
Michael Brines
Anthony Cerami
Thomas Coleman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
H Lundbeck AS
Warren Kenneth S Institute Inc
Original Assignee
H Lundbeck AS
Warren Kenneth S Institute Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by H Lundbeck AS, Warren Kenneth S Institute Inc filed Critical H Lundbeck AS
Publication of AU2004319797A1 publication Critical patent/AU2004319797A1/en
Publication of AU2004319797A8 publication Critical patent/AU2004319797A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1816—Erythropoietin [EPO]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU2004319797A 2003-05-19 2004-05-20 Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs with an extended therapeutic window Abandoned AU2004319797A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60/471,661 2003-05-19
PCT/US2004/015863 WO2005117927A2 (fr) 2004-05-20 2004-05-20 Cytokines protegeant les tissus pour la protection, la restauration et l'augmentation des cellules receptives, des tissus et des organes par une fenetre therapeutique etendue

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2004/015733 Division WO2004112693A2 (fr) 2003-05-19 2004-05-19 Cytokines de protection tissulaire pour la protection, la restauration, et l'amelioration de cellules, tissus et organes sensibles avec une fenetre therapeutique etendue

Publications (2)

Publication Number Publication Date
AU2004319797A1 true AU2004319797A1 (en) 2006-01-12
AU2004319797A8 AU2004319797A8 (en) 2008-12-11

Family

ID=35463339

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2004319797A Abandoned AU2004319797A1 (en) 2003-05-19 2004-05-20 Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs with an extended therapeutic window

Country Status (7)

Country Link
CN (1) CN1897960A (fr)
AU (1) AU2004319797A1 (fr)
BR (1) BRPI0412869A (fr)
IL (1) IL172036A0 (fr)
IS (1) IS8222A (fr)
NO (1) NO20062506L (fr)
WO (1) WO2005117927A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7718363B2 (en) 2003-04-25 2010-05-18 The Kenneth S. Warren Institute, Inc. Tissue protective cytokine receptor complex and assays for identifying tissue protective compounds
WO2019072411A1 (fr) * 2017-10-10 2019-04-18 Augustinus Bader Application d'érythropoïétine (epo) dans une thérapie de lésion de la moelle épinière (lme)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7300915B2 (en) * 2002-06-05 2007-11-27 The Regents Of The University Of California Use of erythropoietin and erythropoietin mimetics for the treatment of neuropathic pain
US20040091961A1 (en) * 2002-11-08 2004-05-13 Evans Glen A. Enhanced variants of erythropoietin and methods of use
RU2341284C2 (ru) * 2003-03-27 2008-12-20 Янссен Фармацевтика Нв Применение эритропоэтина в восстановлении после инсульта

Also Published As

Publication number Publication date
WO2005117927A3 (fr) 2006-05-11
IL172036A0 (en) 2009-02-11
NO20062506L (no) 2006-05-31
WO2005117927A2 (fr) 2005-12-15
AU2004319797A8 (en) 2008-12-11
IS8222A (is) 2006-01-10
CN1897960A (zh) 2007-01-17
BRPI0412869A (pt) 2006-10-03

Similar Documents

Publication Publication Date Title
US20090258821A1 (en) Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs with an extended therapeutic window
EP0309100B1 (fr) Emploi de l'amyline ou CGRP pour le traitement du diabète sucré
US6531121B2 (en) Protection and enhancement of erythropoietin-responsive cells, tissues and organs
US5175145A (en) Treatment of diabetes mellitus with amylin agonists
NO20032912L (no) Beskyttelse, gjenoppbygging og styrking av erytropoietinresponsive celler, vev og organer.
DK2598160T3 (en) Stabilization of FSH
MXPA06014742A (es) Nueva epo carbamilada y metodo para su produccion.
JP4147329B2 (ja) 液体形態の改良された安定性を有するコルチコトロピン放出因子の医薬製剤
JP5208135B2 (ja) 組換え白血球阻害因子とヒルゲンのキメラタンパク質及びその薬物組成物
US20100152117A1 (en) Aequorin-Containing Compositions and Methods of Using Same
AU2004319797A8 (en) Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs with an extended therapeutic window
US6288028B1 (en) BPC peptide salts with organo-protective activity, the process for their preparation and their use in therapy
US20170252403A1 (en) Methods and compositions for treating retinal disorders
MXPA06000690A (en) Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs with an extended therapeutic window
EP2842557A1 (fr) Mildronate dans des troubles ophtalmiques
KR20060084844A (ko) 확장된 치료 윈도우를 갖는, 반응성 세포, 조직 및 기관의보호, 회복 및 개선을 위한 조직 보호성 사이토카인
CA2619721A1 (fr) Utilisation du facteur de croissance du nerf dans des gouttes ophtalmiques pour le traitement de pathologies du systeme nerveux central telles que la maladie d'alzheimer et la maladie de parkinson
EP2816056A1 (fr) Agent améliorant en cas de dysfonctionnement de la barrière hémato-encéphalique
US20110144077A1 (en) Treatment of retinal degeneration

Legal Events

Date Code Title Description
DA3 Amendments made section 104

Free format text: THE NATURE OF THE AMENDMENT IS: ADD PRIORITY DETAILS PCT/ US2004/015733 19 MAY 2004

MK1 Application lapsed section 142(2)(a) - no request for examination in relevant period
TH Corrigenda

Free format text: IN VOL 20, NO 2, PAGE(S) 159 UNDER THE HEADING PCT APPLICATIONS THAT HAVE ENTERED THE NATIONAL PHASE - NAME INDEX UNDER THE NAME H. LUNDBECK A/S AND THE KENNETH S. WARREN INSTITUTE, INC., APPLICATION NO. 2004319797, UNDER INID (43), CORRECT THE DATE TO 15 DECEMBER

Free format text: IN VOL 20, NO 2, PAGE(S) 121 UNDER THE HEADING APPLICATIONS OPI - NAME INDEX UNDER THE NAME H. LUNDBECK A/S AND THE KENNETH S. WARREN INSTITUTE, INC., APPLICATION NO. 2004319797, UNDER INID (43), CORRECT THE DATE TO 15 DECEMBER 2005